Early Discharge After Primary PCI Deemed Safe in STEMI

This article originally appeared here.
Share this content:
Early Discharge After Primary PCI Deemed Safe in STEMI
Early Discharge After Primary PCI Deemed Safe in STEMI

MONDAY, June 20, 2016 (HealthDay News) -- For patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (PPCI), an early discharge strategy within 48 to 56 hours is safe, according to a study published in the June 15 issue of The American Journal of Cardiology.

M. Hulusi Satilmisoglu, M.D., from Mehmet Akif Ersoy Chest and Cardiovascular Surgery Training and Research Hospital in Istanbul, and colleagues examined whether an early discharge strategy (within 48 to 56 hours) is safe for patients with successful PPCI. A total of 769 eligible patients with ST-elevation myocardial infarction were randomized to the early or standard discharge group.

The researchers found that the length of hospital stay was significantly shorter for the early discharge versus the standard discharge group (45.99 ± 9.12 versus 114.87 ± 63.53 hours; P < 0.0001). The study groups did not differ in terms of all-cause mortality (P = 0.684) or readmissions (P = 0.061). No significant between-group difference was seen for quality-of-life measures.

"Our study reveals that discharge within 48 to 56 hours after successful PPCI is feasible, safe, and does not increase the 30-day readmission rate," the authors write. "Moreover, the patients perceived health status at 30 days did not differ with early discharge."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

SABCS: Artificial Intelligence May Aid Doctors in Breast ...

'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

Devices reduce blood flow to hair follicles during chemotherapy treatments

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

Women on aromatase inhibitors exhibit less elasticity in their blood vessels

is free, fast, and customized just for you!

Already a member?

Sign In Now »